BioXtal, Speeding up your discoveries. From DNA to 3D structure.

Quick-off meeting of Synsignal: An EU FP7 7M€ funded consortium involving Bio-Xtal with 6 other partners will be dedicated to the development of synthetic pathway related to GPCR signaling.


BIO San Diego: Meet us in San Diego to the 2014 BIO International Convention


BioXtal as concluded a licencing Agreement with LifeTechnologies for the development of tetracycline inducible mammalian stable cell lines.


Bio-Xtal in association with the CEA is proposing a new expertise to develop scaffold free binders based on Stamps™ technology.